A peptide known as caerulein can convert existing pancreatic cells to cells destroyed in type 1 diabetes insulin producing cells, a new study has found. The study, published online July 31 in iCell Death and Disease/i, suggests a new approach to treating the estimated 3 million people in the U.S., and over 300 million worldwide, living with type 1 diabetes. "We have found a promising technique for type 1 diabetics to restore the body's ability to produce insulin. ...
Read More
No comments:
Post a Comment